These 4 'High-Potential' Biotech Stocks Could Outperform in 2013

Published May 5, 2013

These 4 'High-Potential' Biotech Stocks Could Outperform In 2013
This stock was trading for over $ 2 in September 2012, on hopes that it would announce positive data for CPP-109 which it was developing for the treatment of cocaine and methamphetamine addiction, however, the news disappointed investors and the …
Read more on Seeking Alpha

One Call Away: Drug accessibility on the rise
“It takes me less than a day to track down marijuana, Adderall, acid, mushrooms, molly and maybe another day or two for cocaine,” Western student and dealer Gratian said. All Gratian … “Having worked here 24 years, there is no question we are seeing …
Read more on Western Front